Published in Chem Res Toxicol on January 01, 1998
Genetic effects of oxidative DNA damages: comparative mutagenesis of the imidazole ring-opened formamidopyrimidines (Fapy lesions) and 8-oxo-purines in simian kidney cells. Nucleic Acids Res (2006) 1.51
Biological properties of single chemical-DNA adducts: a twenty year perspective. Chem Res Toxicol (2007) 1.24
Mutagenicity of the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in mammalian cells. Chem Res Toxicol (2007) 0.99
Differential toxicity of DNA adducts of mitomycin C. J Nucleic Acids (2010) 0.89
Synthesis of an oligodeoxyribonucleotide adduct of mitomycin C by the postoligomerization method via a triamino mitosene. J Am Chem Soc (2008) 0.85
Site-specifically located 8-amino-2'-deoxyguanosine: thermodynamic stability and mutagenic properties in Escherichia coli. Nucleic Acids Res (2001) 0.81
Comparative Error-Free and Error-Prone Translesion Synthesis of N(2)-2'-Deoxyguanosine Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene, in Human Cells. Chem Res Toxicol (2016) 0.80
Identification of Escherichia coli ygaQ and rpmG as novel mitomycin C resistance factors implicated in DNA repair. Biosci Rep (2015) 0.75
Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer (1996) 2.24
Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (1987) 1.91
Mutagenicity of nitroaromatic compounds. Chem Res Toxicol (2000) 1.61
Circular dichroism of mitomycin-DNA complexes. Evidence for a conformational change in DNA. Biochemistry (1977) 1.57
Both purified human 1,N6-ethenoadenine-binding protein and purified human 3-methyladenine-DNA glycosylase act on 1,N6-ethenoadenine and 3-methyladenine. Proc Natl Acad Sci U S A (1992) 1.54
Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med (1967) 1.51
Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol (2000) 1.48
Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor. J Biol Chem (2001) 1.30
Replication inhibition and miscoding properties of DNA templates containing a site-specific cis-thymine glycol or urea residue. Chem Res Toxicol (1998) 1.29
The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro. Biochemistry (1974) 1.24
Nuclear magnetic resonance solution structures of covalent aromatic amine-DNA adducts and their mutagenic relevance. Chem Res Toxicol (1998) 1.22
Reaction of DNA with chemically or enzymatically activated mitomycin C: isolation and structure of the major covalent adduct. Proc Natl Acad Sci U S A (1986) 1.16
Recognition between mitomycin C and specific DNA sequences for cross-link formation. Biochemistry (1990) 1.15
Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol (1977) 1.15
Site-specific mutagenesis by O6-alkylguanines located in the chromosomes of mammalian cells: influence of the mammalian O6-alkylguanine-DNA alkyltransferase. Proc Natl Acad Sci U S A (1989) 1.14
The pacemaker-twiddler's syndrome: another disadvantage of abdominal implantation of pulse generators. Br J Surg (1977) 1.12
Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res (1967) 1.08
Recognition and incision of site-specifically modified C8 guanine adducts formed by 2-aminofluorene, N-acetyl-2-aminofluorene and 1-nitropyrene by UvrABC nuclease. Nucleic Acids Res (2000) 1.07
Mitomycin C: a prototype bioreductive agent. Oncol Res (1994) 1.06
Unequivocal demonstration that malondialdehyde is a mutagen. Carcinogenesis (1983) 1.05
Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development. Biochem Pharmacol (1998) 1.05
Mechanism of the isotopic exchange of the C-8 hydrogen of purines in nucleosides and in deoxyribonucleic acid. Biochemistry (1972) 1.04
NMR and computational characterization of mitomycin cross-linked to adjacent deoxyguanosines in the minor groove of the d(T-A-C-G-T-A).d(T-A-C-G-T-A) duplex. Biochemistry (1990) 1.03
Solution conformation of the N-(deoxyguanosin-8-yl)-1-aminopyrene ([AP]dG) adduct opposite dC in a DNA duplex. Biochemistry (1996) 1.01
Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C. Biochemistry (1988) 1.00
Cardiac pacing in India (a perspective and prospective study). J Indian Med Assoc (1980) 1.00
Site-specific frame-shift mutagenesis by the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-y1)-1-aminopyrene located in the (CG)3 sequence: effects of SOS, proofreading, and mismatch repair. Biochemistry (1996) 0.99
Isolation and structure of an intrastrand cross-link adduct of mitomycin C and DNA. Biochemistry (1992) 0.99
Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev (1993) 0.99
A study on dyslipidaemia in subclinical hypothyroidism. J Indian Med Assoc (2006) 0.98
Posterior urethral valves: the scenario in a developing center. Pediatr Surg Int (2001) 0.98
Recognition of specific DNA sequences by mitomycin C for alkylation. Biochemistry (1992) 0.97
Direct splenocaval shunt for selective decompression of portal hypertension in children. Surgery (1980) 0.97
Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C. Biochemistry (1997) 0.97
Reaction of acid-activated mitomycin C with calf thymus DNA and model guanines: elucidation of the base-catalyzed degradation of N7-alkylguanine nucleosides. Biochemistry (1987) 0.96
Effect of plasma-volume expansion on portal hypertension. N Engl J Med (1966) 0.96
Selective recognition of the m5CpG dinucleotide sequence in DNA by mitomycin C for alkylation and cross-linking. Bioorg Med Chem (1995) 0.96
O6-alkyldeoxyguanosine detection by 32P-postlabeling and nucleotide chromatographic analysis. Cancer Res (1988) 0.96
Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. II. Histopathological studies. Indian J Med Res (1967) 0.96
Extrahepatic obstruction of the portal venous system. Surg Gynecol Obstet (1968) 0.93
Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry (1981) 0.93
Bending of DNA by the mitomycin C-induced, GpG intrastrand cross-link. Chem Res Toxicol (1996) 0.93
Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells. Chem Res Toxicol (1997) 0.93
Lack of Z-DNA conformation in mitomycin-modified polynucleotides having inverted circular dichroism. Proc Natl Acad Sci U S A (1983) 0.92
Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns. Cancer Res (1993) 0.91
The chemistry of pseudouridine. VII. Selective cleavage of polynucleotides containing pseudouridylic acid residues by a unique photochemical reaction. Biochemistry (1966) 0.91
Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents. Cancer Res (1998) 0.91
Previous medication, duration of illness and placebo response. J Nerv Ment Dis (1966) 0.90
Unusual cold abscesses. Br J Surg (1970) 0.90
Novel assay of 7-alkylation of guanine residues in DNA. Application to nitrogen mustard, triethylenemelamine and mitomycin C. Biochim Biophys Acta (1970) 0.90
Extreme lability of the C-8 proton: a consequence of 7-methylation of guanine residues in model compounds and in DNA and its analytical application. Biochim Biophys Acta (1970) 0.89
Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells. Chem Res Toxicol (2000) 0.89
Differential incision of bulky carcinogen-DNA adducts by the UvrABC nuclease: comparison of incision rates and the interactions of Uvr subunits with lesions of different structures. Biochemistry (2000) 0.89
Effect of site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. Biochemistry (1993) 0.88
H2O2 generation during the redox cycle of mitomycin C and dna-bound mitomycin C. Chem Biol Interact (1976) 0.88
Solution structure of the monoalkylated mitomycin C-DNA complex. J Mol Biol (1995) 0.88
Electrostatic complexes of mitomycin C with nucleic acids and polyanions. Biochim Biophys Acta (1978) 0.88
Reductive activation of mitomycin A by thiols. Org Lett (2001) 0.87
Effects of caloric restriction on expression of testicular cytochrome P450 enzymes associated with the metabolic activation of carcinogens. Arch Biochem Biophys (1996) 0.87
Solution structure of the N-(deoxyguanosin-8-yl)-1-aminopyrene ([AP]dG) adduct opposite dA in a DNA duplex. Biochemistry (1999) 0.87
Molecular requirements for the mutagenicity of malondialdehyde and related acroleins. Cancer Res (1984) 0.87
Prevalence of bovine trypanosomosis and trypanocidal drug sensitivity studies on Trypanosoma congolense in Wolyta and Dawero zones of southern Ethiopia. Vet Parasitol (2007) 0.87
Reassignment of the guanine-binding mode of reduced mitomycin C. Biochemistry (1986) 0.86
Patterns of the drug habit in hospitalized psychiatric patients. Bull Narc (1975) 0.86
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C. Oncol Res (1998) 0.85
Renal and hepatic family 3A cytochromes P450 (CYP3A) in spontaneously hypertensive rats. Biochem Pharmacol (1995) 0.85
A probe for the mutagenic activity of the carcinogen 4-aminobiphenyl: synthesis and characterization of an M13mp10 genome containing the major carcinogen-DNA adduct at a unique site. Biochemistry (1987) 0.84
Parasitological and clinical responses of lambs experimentally infected with Haemonchus contortus (L3) with and without ivermectin treatment. Vet Parasitol (2009) 0.84
Altered physiochemical properties of the deoxyribonucleic acid-mitomycin C complex. Evidence for the conformational change in deoxyribonucleic acid. Biochemistry (1982) 0.84
Distribution and oxidation of malondialdehyde in mice. Prostaglandins (1985) 0.84
Synthesis and characterization of oligodeoxynucleotides containing the major DNA adducts formed by 1,6- and 1,8-dinitropyrene. Org Lett (2000) 0.84
Mutagenicity of the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in Escherichia coli located in a nonrepetitive CGC sequence. Chem Res Toxicol (2000) 0.83
A histopathological study of liver and biliary remnants with clinical outcome in cases of extrahepatic biliary atresia. Indian J Pathol Microbiol (2010) 0.83
Reactivity of mitomycin C with synthetic polyribonucleotides containing guanine or guanine analogs. Biochim Biophys Acta (1982) 0.83
Duplex oligodeoxyribonucleotides cross-linked by mitomycin C at a single site: synthesis, properties, and cross-link reversibility. Biochemistry (1990) 0.83
Mitomycin C linked to DNA minor groove binding agents: synthesis, reductive activation, DNA binding and cross-linking properties and in vitro antitumor activity. Bioorg Med Chem (1999) 0.83
Vacuum ultraviolet circular dichroism of double stranded nucleic acids. Photochem Photobiol (1986) 0.82
Technetium-99m-HMPAO SPECT cerebral blood flow study in children with craniosynostosis. J Nucl Med (1995) 0.82
Long-term follow-up studies of 'non-cirrhotic portal fibrosis' after surgery. Br J Surg (1969) 0.82
Calorie restriction modulates age-dependent changes in the retinas of Brown Norway rats. Mech Ageing Dev (2000) 0.82
Site-specifically located 8-amino-2'-deoxyguanosine: thermodynamic stability and mutagenic properties in Escherichia coli. Nucleic Acids Res (2001) 0.81
Plasma volume expansion in portal hypertension. Johns Hopkins Med J (1969) 0.81
C8-guanine adduct-induced stabilization of a -1 frame shift intermediate in a nonrepetitive DNA sequence. Biochemistry (1999) 0.81
The optimal dose of pentagastrin to elicit maximal acid response in Indians. Indian J Med Res (1981) 0.81
Solution properties and computational analysis of an oligodeoxynucleotide containing N-(deoxyguanosin-8-yl)-1-aminopyrene. Carcinogenesis (1996) 0.81
Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cells. Adv Enzyme Regul (1993) 0.80